Rebecca Taub

For Rebecca Taub, understanding liver regeneration may hold the key to at least one medical mystery. "If we can understand what happens during the growth of normal cells, we can understand cancerous growth," she explains. There are a number of clinical syndromes in which the liver regenerates itself, including toxic damage to the liver by alcohol, acetaminophen, and infections such as hepatitis. Understanding what triggers regeneration, how the liver functions while the cells are replicating,

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

There are a number of clinical syndromes in which the liver regenerates itself, including toxic damage to the liver by alcohol, acetaminophen, and infections such as hepatitis. Understanding what triggers regeneration, how the liver functions while the cells are replicating, and how the liver knows when to stop may hold the key to successful liver transplants, treatment of liver diseases, and-ultimately-an understanding of cancer cell growth.

Taub has focused on analyzing the initializing events of liver regeneration by looking at what genes are activated in the liver remnant within minutes of a partial hepatectomy. She and her colleagues have identified some of the signals that allow hepatocytes to go into cell growth, and have isolated two transcription factors-NF-kappa B and Stat 3-that come on within minutes to hours.

"What is interesting about finding those factors is that we can then ask what growth factors and cytokines turn on those factors ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies